Is TetraLogic Pharmaceuticals Corp halal to invest in?

According to Musaffa's Shariah screening methodology, TetraLogic Pharmaceuticals Corp (TLOG) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is TetraLogic Pharmaceuticals Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes TetraLogic Pharmaceuticals Corp using these criteria to determine its compliance status.

Can Muslims buy shares of TetraLogic Pharmaceuticals Corp?

Muslim investors may consider investing in TetraLogic Pharmaceuticals Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is TetraLogic Pharmaceuticals Corp classified as NOT COVERED?

Musaffa determines the Shariah status of TetraLogic Pharmaceuticals Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for TetraLogic Pharmaceuticals Corp updated?

The Shariah compliance status of TetraLogic Pharmaceuticals Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like TetraLogic Pharmaceuticals Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of TetraLogic Pharmaceuticals Corp?

You can check the latest Shariah compliance status of TetraLogic Pharmaceuticals Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

TetraLogic Pharmaceuticals Corp. Stock Analysis TLOG

United States Health Care Nano Cap

TetraLogic Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel small molecule therapeutics in oncology and infectious diseases. The company is headquartered in Malvern, Pennsylvania and currently employs 29 full-time employees. The company went IPO on 2013-12-12. The firm is focused on discovering and developing small molecule therapeutics in oncology, infectious diseases and autoimmune diseases. The firm's segment is the identification and development of novel small molecule therapies in oncology and infectious diseases. The firm has approximately two clinical-stage product candidates in development, such as birinapant and SHAPE. SHAPE is the Company's histone deacetylase (HDAC) inhibitor that it is developing for topical use for the treatment of early-stage cutaneous T-cell lymphoma (CTCL). The firm is also exploring studying SHAPE in alopecia areata, an autoimmune skin disease. SHAPE has been granted the United States orphan drug designation for CTCL. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases (SMAC)-mimetic, which leads to apoptosis or cell-death in damaged cells.

Key Statistics of TetraLogic Pharmaceuticals Corp (TLOG)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.00$0.00

Today's Open

$0.00

Volume

500.00

P/E Ratio (TTM)

52 Week Range

$0.00$0.00

Market Cap

4893.00

Avg. Volume

475.00

Dividend Yield

Financial Metrics & Statements of TetraLogic Pharmaceuticals Corp (TLOG)

FAQ's for TetraLogic Pharmaceuticals Corp (TLOG)

According to Musaffa’s Shariah screening methodology, TetraLogic Pharmaceuticals Corp (TLOG) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.